List of Tables
Table 1. Global Tropical and Vector-borne Infectious Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Tropical and Vector-borne Infectious Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Tropical and Vector-borne Infectious Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Tropical and Vector-borne Infectious Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Tropical and Vector-borne Infectious Diseases Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Tropical and Vector-borne Infectious Diseases Sales by Region (2020-2025) & (K Units)
Table 8. Global Tropical and Vector-borne Infectious Diseases Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Tropical and Vector-borne Infectious Diseases Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Tropical and Vector-borne Infectious Diseases Sales Share by Manufacturers (2020-2025)
Table 12. Global Tropical and Vector-borne Infectious Diseases Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Tropical and Vector-borne Infectious Diseases by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tropical and Vector-borne Infectious Diseases as of 2024)
Table 16. Global Tropical and Vector-borne Infectious Diseases Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Tropical and Vector-borne Infectious Diseases Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Tropical and Vector-borne Infectious Diseases Manufacturing Base and Headquarters
Table 19. Global Tropical and Vector-borne Infectious Diseases Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Tropical and Vector-borne Infectious Diseases Sales by Type (2020-2025) & (K Units)
Table 23. Global Tropical and Vector-borne Infectious Diseases Sales by Type (2026-2031) & (K Units)
Table 24. Global Tropical and Vector-borne Infectious Diseases Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Tropical and Vector-borne Infectious Diseases Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Tropical and Vector-borne Infectious Diseases ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Tropical and Vector-borne Infectious Diseases Sales by Application (2020-2025) & (K Units)
Table 29. Global Tropical and Vector-borne Infectious Diseases Sales by Application (2026-2031) & (K Units)
Table 30. Tropical and Vector-borne Infectious Diseases High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Tropical and Vector-borne Infectious Diseases Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Tropical and Vector-borne Infectious Diseases Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Tropical and Vector-borne Infectious Diseases ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Tropical and Vector-borne Infectious Diseases Growth Accelerators and Market Barriers
Table 37. North America Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Tropical and Vector-borne Infectious Diseases Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Tropical and Vector-borne Infectious Diseases Growth Accelerators and Market Barriers
Table 40. Europe Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Tropical and Vector-borne Infectious Diseases Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Tropical and Vector-borne Infectious Diseases Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Tropical and Vector-borne Infectious Diseases Growth Accelerators and Market Barriers
Table 45. Southeast Asia Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Tropical and Vector-borne Infectious Diseases Investment Opportunities and Key Challenges
Table 47. Central and South America Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Tropical and Vector-borne Infectious Diseases Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bio-Mapper Corporation Information
Table 51. Bio-Mapper Description and Major Businesses
Table 52. Bio-Mapper Product Models, Descriptions and Specifications
Table 53. Bio-Mapper Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Bio-Mapper Sales Value Proportion by Product in 2024
Table 55. Bio-Mapper Sales Value Proportion by Application in 2024
Table 56. Bio-Mapper Sales Value Proportion by Geographic Area in 2024
Table 57. Bio-Mapper Tropical and Vector-borne Infectious Diseases SWOT Analysis
Table 58. Bio-Mapper Recent Developments
Table 59. Meridian Corporation Information
Table 60. Meridian Description and Major Businesses
Table 61. Meridian Product Models, Descriptions and Specifications
Table 62. Meridian Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Meridian Sales Value Proportion by Product in 2024
Table 64. Meridian Sales Value Proportion by Application in 2024
Table 65. Meridian Sales Value Proportion by Geographic Area in 2024
Table 66. Meridian Tropical and Vector-borne Infectious Diseases SWOT Analysis
Table 67. Meridian Recent Developments
Table 68. Bharat Biotech Corporation Information
Table 69. Bharat Biotech Description and Major Businesses
Table 70. Bharat Biotech Product Models, Descriptions and Specifications
Table 71. Bharat Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Bharat Biotech Sales Value Proportion by Product in 2024
Table 73. Bharat Biotech Sales Value Proportion by Application in 2024
Table 74. Bharat Biotech Sales Value Proportion by Geographic Area in 2024
Table 75. Bharat Biotech Tropical and Vector-borne Infectious Diseases SWOT Analysis
Table 76. Bharat Biotech Recent Developments
Table 77. Inovio Pharmaceuticals and GeneOne Life Sciences Corporation Information
Table 78. Inovio Pharmaceuticals and GeneOne Life Sciences Description and Major Businesses
Table 79. Inovio Pharmaceuticals and GeneOne Life Sciences Product Models, Descriptions and Specifications
Table 80. Inovio Pharmaceuticals and GeneOne Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Inovio Pharmaceuticals and GeneOne Life Sciences Sales Value Proportion by Product in 2024
Table 82. Inovio Pharmaceuticals and GeneOne Life Sciences Sales Value Proportion by Application in 2024
Table 83. Inovio Pharmaceuticals and GeneOne Life Sciences Sales Value Proportion by Geographic Area in 2024
Table 84. Inovio Pharmaceuticals and GeneOne Life Sciences Tropical and Vector-borne Infectious Diseases SWOT Analysis
Table 85. Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments
Table 86. Intrexon Corporation Information
Table 87. Intrexon Description and Major Businesses
Table 88. Intrexon Product Models, Descriptions and Specifications
Table 89. Intrexon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Intrexon Sales Value Proportion by Product in 2024
Table 91. Intrexon Sales Value Proportion by Application in 2024
Table 92. Intrexon Sales Value Proportion by Geographic Area in 2024
Table 93. Intrexon Tropical and Vector-borne Infectious Diseases SWOT Analysis
Table 94. Intrexon Recent Developments
Table 95. Cerus Corporation Information
Table 96. Cerus Description and Major Businesses
Table 97. Cerus Product Models, Descriptions and Specifications
Table 98. Cerus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Cerus Recent Developments
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi Product Models, Descriptions and Specifications
Table 103. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Sanofi Recent Developments
Table 105. Lumos Pharma Corporation Information
Table 106. Lumos Pharma Description and Major Businesses
Table 107. Lumos Pharma Product Models, Descriptions and Specifications
Table 108. Lumos Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Lumos Pharma Recent Developments
Table 110. Coyote Bio Corporation Information
Table 111. Coyote Bio Description and Major Businesses
Table 112. Coyote Bio Product Models, Descriptions and Specifications
Table 113. Coyote Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Coyote Bio Recent Developments
Table 115. GlaxoSmithKline Corporation Information
Table 116. GlaxoSmithKline Description and Major Businesses
Table 117. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 118. GlaxoSmithKline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. GlaxoSmithKline Recent Developments
Table 120. Primerdesign Corporation Information
Table 121. Primerdesign Description and Major Businesses
Table 122. Primerdesign Product Models, Descriptions and Specifications
Table 123. Primerdesign Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Primerdesign Recent Developments
Table 125. Bio-Manguinhos Corporation Information
Table 126. Bio-Manguinhos Description and Major Businesses
Table 127. Bio-Manguinhos Product Models, Descriptions and Specifications
Table 128. Bio-Manguinhos Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Bio-Manguinhos Recent Developments
Table 130. Chumakov Corporation Information
Table 131. Chumakov Description and Major Businesses
Table 132. Chumakov Product Models, Descriptions and Specifications
Table 133. Chumakov Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Chumakov Recent Developments
Table 135. Institut Pasteur de Dakar Corporation Information
Table 136. Institut Pasteur de Dakar Description and Major Businesses
Table 137. Institut Pasteur de Dakar Product Models, Descriptions and Specifications
Table 138. Institut Pasteur de Dakar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Institut Pasteur de Dakar Recent Developments
Table 140. Roche Diagnostics Corporation Information
Table 141. Roche Diagnostics Description and Major Businesses
Table 142. Roche Diagnostics Product Models, Descriptions and Specifications
Table 143. Roche Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Roche Diagnostics Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Tropical and Vector-borne Infectious Diseases Product Picture
Figure 2. Global Tropical and Vector-borne Infectious Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Drugs Product Picture
Figure 4. Diagnostic Reagent Product Picture
Figure 5. Global Tropical and Vector-borne Infectious Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Tropical and Vector-borne Infectious Diseases Report Years Considered
Figure 10. Global Tropical and Vector-borne Infectious Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 12. Global Tropical and Vector-borne Infectious Diseases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Region (2020-2031)
Figure 14. Global Tropical and Vector-borne Infectious Diseases Sales (2020-2031) & (K Units)
Figure 15. Global Tropical and Vector-borne Infectious Diseases Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Tropical and Vector-borne Infectious Diseases Sales Volume Market Share in 2024
Figure 18. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Drugs Revenue Market Share by Manufacturer in 2024
Figure 21. Diagnostic Reagent Revenue Market Share by Manufacturer in 2024
Figure 22. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Type (2020-2031)
Figure 23. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Type (2020-2031)
Figure 24. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Application (2020-2031)
Figure 25. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Application (2020-2031)
Figure 26. North America Tropical and Vector-borne Infectious Diseases Sales YoY (2020-2031) & (K Units)
Figure 27. North America Tropical and Vector-borne Infectious Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) in 2024
Figure 29. North America Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Tropical and Vector-borne Infectious Diseases Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Tropical and Vector-borne Infectious Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) in 2024
Figure 39. Europe Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 44. France Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Tropical and Vector-borne Infectious Diseases Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Tropical and Vector-borne Infectious Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 59. India Tropical and Vector-borne Infectious Diseases Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Tropical and Vector-borne Infectious Diseases Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Tropical and Vector-borne Infectious Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Tropical and Vector-borne Infectious Diseases Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Tropical and Vector-borne Infectious Diseases Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Tropical and Vector-borne Infectious Diseases Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Tropical and Vector-borne Infectious Diseases Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Tropical and Vector-borne Infectious Diseases Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Tropical and Vector-borne Infectious Diseases Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Tropical and Vector-borne Infectious Diseases Revenue (2020-2025) & (US$ Million)
Figure 80. Tropical and Vector-borne Infectious Diseases Industry Chain Mapping
Figure 81. Regional Tropical and Vector-borne Infectious Diseases Manufacturing Base Distribution (%)
Figure 82. Global Tropical and Vector-borne Infectious Diseases Production Market Share by Region (2020-2031)
Figure 83. Tropical and Vector-borne Infectious Diseases Production Process
Figure 84. Regional Tropical and Vector-borne Infectious Diseases Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
